Neurological Adverse Reactions to Anticancer Drugs

  • Jerzy Hildebrand
Conference proceedings

Part of the ESO Monographs book series (ESO MONOGRAPHS)

Table of contents

  1. Front Matter
    Pages I-VII
  2. Jerzy Hildebrand
    Pages 1-1
  3. Diamon Gangji, Jerzy Hildebrand, Roland Gerritsen van der Hoop
    Pages 25-43
  4. Roland Gerritsen van der Hoop, Lisa M. DeAngelis, Jerome B. Posner
    Pages 45-53
  5. Jerome B. Posner
    Pages 55-65
  6. Francesc Graus
    Pages 67-73
  7. Jerome B. Posner
    Pages 75-81
  8. Jerzy Hildebrand
    Pages 83-85
  9. Jerzy Hildebrand
    Pages 93-99

About these proceedings

Introduction

In this timely and up-to-date book, the latest knowledge on neurological syndromes due to neurotoxicity of antineoplastic drugs is presented. The initial chapters discuss the following vital topics: - the importance of blood-brain barrier changes in cancer patients, - laboratory and clinical studies on the neurotoxicity of anticancer drugs, - and the role of cumulative toxicity of radiation therapy and chemotherapy. Clinical presentation and diagnosis of various neurological conditions related to antineoplastic chemotherapy are then also thoroughly discussed. Indispensable to the neuro-oncologist and useful to all physicians managing cancer patients, this book is a valuable source of current information.

Keywords

Antineoplastic drugs cancer chemotherapy nervous system neurotoxicity oncology physiology radiation therapy toxicity

Editors and affiliations

  • Jerzy Hildebrand
    • 1
  1. 1.Service de NeurologieHôpital Erasme Université Libre de BruxellesBruxellesBelgium

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-76142-3
  • Copyright Information Springer-Verlag Berlin Heidelberg 1990
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-76144-7
  • Online ISBN 978-3-642-76142-3
  • About this book